Carotid plaque and candidate genes related to inflammation and endothelial function in hispanics from Northern Manhattan

Stroke

Volumn 42, Issue 4, 2011, Pages 889-896

  Gardener, Hannah ^a   Beecham, Ashley ^a   Cabral, Digna ^a   Yanuck, Danielle ^a   Slifer, Susan ^a   Wang, Liyong ^a   Blanton, Susan H ^a   Sacco, Ralph L ^a   Juo, Suh Hang Hank ^b   Rundek, Tatjana ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

candidate gene; carotid plaque; inflammation; single nucleotide polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1ALPHA; INTERLEUKIN 6 RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OX40 LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; XRCC1 PROTEIN;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

AGED; CAROTID STENOSIS; DNA MUTATIONAL ANALYSIS; ENDOTHELIAL CELLS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HISPANIC AMERICANS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEW YORK CITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79954946123     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.591065     Document Type: Article

References (33)

1. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology. 2008;70:1200-1207. (Pubitemid 351482586)
2. Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, Sacco RL. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke. 2006;37:2696-2701. (Pubitemid 44922528)
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
4. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-1890. (Pubitemid 34219736)
5. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke. 2005;36:5-8. (Pubitemid 40054167)
6. Sayed-Tabatabaei FA, van Rijn MJ, Schut AF, Aulchenko YS, Croes EA, Zillikens MC, Pols HA, Witteman JC, Oostra BA, van Duijn CM. Heritability of the function and structure of the arterial wall: findings of the Erasmus Rucphen Family (ERF) study. Stroke. 2005;36:2351-2356. (Pubitemid 41566957)
7. Enquobahrie DA, Smith NL, Bis JC, Carty CL, Rice KM, Lumley T, Hindorff LA, Lemaitre RN, Williams MA, Siscovick DS, Heckbert SR, Psaty BM. Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am J Cardiol. 2008;101:1683-1688.
8. Reinhard W, Stark K, Sedlacek K, Fischer M, Baessler A, Neureuther K, Weber S, Kaess B, Wiedmann S, Mitsching S, Lieb W, Erdmann J, Meisinger C, Doering A, Tolle R, Jeron A, Riegger G, Hengstenberg C. Association between PPARalpha gene polymorphisms and myocardial infarction. Clin Sci (Lond). 2008;115:301-308.
9. Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation. 2002;105: 1440-1445. (Pubitemid 34263275)
10. Hayashi T, Matsui-Hirai H, Fukatsu A, Sumi D, Kano-Hayashi H, Rani PJA, Iguchi A. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism Atherosclerosis. 2006;187:316-324. (Pubitemid 43963030)
11. Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, Samnegård A, Petros C, Rollins J, Bennet AM, Wiman B, de Faire U, Wennberg C, Olsson PG, Ishii N, Sugamura K, Hamsten A, Forsman-Semb K, Lagercrantz J, Paigen B. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet. 2005;37:365-372.
12. Shen R, Fan JB, Campbell D, Chang W, Chen J, Doucet D, Yeakley J, Bibikova M, Wickham Garcia E, McBride C, Steemers F, Garcia F, Kermani BG, Gunderson K, Oliphant A. High-throughput SNP genotyping on universal bead arrays. Mutat Res. 2005;573:70-82. (Pubitemid 40514402)
13. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature. 2006;38:904-909. (Pubitemid 44141658)
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
15. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138-147. (Pubitemid 32614026)
16. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003;55:56-65. (Pubitemid 36928747)
17. Becker T, Cichon S, Jönson E, Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet. 2005;69:747-756. (Pubitemid 41556327)
18. Becker T, Schumacher J, Cichon S, Baur MP, Knapp M. Haplotype interaction analysis of unlinked regions. Genet Epidemiol. 2005;29: 313-322. (Pubitemid 41720950)
19. Behr-Roussel D, Rupin A, Sansilvestri-Morel P, Fabiani JN, Verbeuren TJ. Histochemical evidence for inducible nitric oxide synthase in advanced but non-ruptured human atherosclerotic carotid arteries. Histochem J. 2000;32:41-51. (Pubitemid 30204155)
20. Hernesniemi JA, Raitakari OT, Kähönen M, Juonala M, Hutri-Kähönen N, Marniemi J, Viikari J, Lehtimäki T. Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis. 2008;198: 152-159. (Pubitemid 351406370)
21. Norata GD, Garlaschelli K, Ongari M, Raselli S, Grigore L, Benvenuto F, Maggi FM, Catapano AL. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med. 2005;258:21-27. (Pubitemid 40904929)
22. Netea MG, Hijmans A, van Wissen S, Smilde TJ, Trip MD, Kullberg BJ, de Boo T, Van der Meer JW, Kastelein JJ, Stalenhoef AF. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur J Clin Invest. 2004;34:94-99. (Pubitemid 38253608)
23. Labrum R, Bevan S, Sitzer M, Lorenz M, Markus HS. Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke. 2007; 38:1179-1184. (Pubitemid 351664263)
24. Matarin M, Brown WM, Hardy JA, Rich SS, Singleton AB, Brown RD Jr, Brott TG, Worrall BB, Meschia JF, SWISS Study Group, ISGS Study Group, MSGD Study Group. Association of integrin alpha2 gene variants with ischemic stroke. J Cereb Blood Flow Metab. 2008;28:81-89.
25. Nikolopoulos GK, Tsantes AE, Bagos PG, Travlou A, Vaiopoulos G. Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res. 2007;119:501-510. (Pubitemid 46157253)
26. Maeno T, Koyama H, Tahara H, Komatsu M, Emoto M, Shoji T, Inaba M, Miki T, Okuno Y, Nishizawa Y. The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes. Diabetes. 2002;51: 1523-1528. (Pubitemid 34826620)
27. Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost. 2008;99:286-289. (Pubitemid 351230957)
28. Willeit J, Kiechl S, Weimer T, Mair A, Santer P, Wiedermann CJ, Roemisch J. Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis. Circulation. 2003;107: 667-670. (Pubitemid 36222589)
29. Reiner AP, Lange LA, Smith NL, Zakai NA, Cushman M, Folsom AR. Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost. 2009;7:1499-1505.
30. Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ. Genetic markers: progress and potential for cardiovascular disease. Circulation. 2004;109:IV47-IV58.
31. Yamasaki Y, Katakami N, Sakamoto K, Kaneto H, Matsuhisa M, Sato H, Hori M, Haneda M, Kashiwagi A, Tanaka Y, Kawamori R, Kuno S. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care. 2006;29:2445-2451. (Pubitemid 44912250)
32. Liao YC, Lin HF, Rundek T, Cheng R, Guo YC, Sacco RL, Juo SH. Segment-specific genetic effects on carotid intima-media thickness: the Northern Manhattan study. Stroke. 2008;39:3159-3165.
33. Spence JD. Technology insight: ultrasound measurement of carotid plaque-patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;11:611-619. (Pubitemid 44614087)